Cg Oncology Inc
Cg Oncology Inc (CGON) Covered Calls
Cg Oncology Inc trades in the Biotechnology industry with an IV Rank of 4.76%, low versus the past year. CGON's highest covered call setup is the $105.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 28.21% out of the money with 29 days to expiration, a 28.63% return until expiration, and a 360.37% theoretical annualized return. Across the setups shown, annualized returns run from 150.12% to 360.37% at strikes between $90.00 and $140.00, with 29 to 148 days to expiration, as of Nov 19, 2026.
Read more
Running CGON covered calls helps you generate income from Cg Oncology Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CGON covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If CGON stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CGON covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CGON covered call is worth writing.
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
| 2026-12-18 | 29 | 105.00 | 28.21 | 0.35 | 2.05 | 2345.00 | 28.63 | 360.37 | -0.43 | +0.15 | 65 | 1.70 |
| 2026-12-18 | 29 | 100.00 | 22.10 | 0.70 | 3.20 | 1880.00 | 22.95 | 288.91 | -0.85 | +0.21 | 34 | 2.50 |
| 2027-01-15 | 57 | 115.00 | 40.42 | 0.50 | 2.40 | 3360.00 | 41.03 | 262.71 | -0.61 | +0.14 | 20 | 1.90 |
| 2027-01-15 | 57 | 110.00 | 34.31 | 1.10 | 2.85 | 2920.00 | 35.65 | 228.31 | -1.34 | +0.18 | 5,904 | 1.75 |
| 2026-12-18 | 29 | 95.00 | 16.00 | 0.25 | 2.85 | 1335.00 | 16.30 | 205.16 | -0.31 | +0.22 | 92 | 2.60 |
| 2027-01-15 | 57 | 105.00 | 28.21 | 1.10 | 2.90 | 2420.00 | 29.55 | 189.21 | -1.34 | +0.20 | 988 | 1.80 |
| 2027-04-16 | 148 | 140.00 | 70.94 | 0.10 | 5.00 | 5820.00 | 71.06 | 175.25 | -0.12 | +0.16 | 0 | 4.90 |
| 2026-12-18 | 29 | 90.00 | 9.89 | 2.90 | 4.60 | 1100.00 | 13.43 | 169.05 | -3.54 | +0.37 | 357 | 1.70 |
| 2027-04-16 | 148 | 135.00 | 64.84 | 0.10 | 5.00 | 5320.00 | 64.96 | 160.20 | -0.12 | +0.17 | 0 | 4.90 |
| 2027-01-15 | 57 | 100.00 | 22.10 | 1.10 | 3.90 | 1920.00 | 23.44 | 150.12 | -1.34 | +0.24 | 220 | 2.80 |
As of Nov 19, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank4.76% Low
- Market cap (M$)7,098
- 52 weeks high-15.41%
- 52 weeks low114.73%
- Analyst recommendationStrong Buy
1.27 - Target price$109.69
38.03% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-06
- P/E—
- Future P/E—
- EPS (ttm)-2.76
- EPS growth next 5 years34.18%
As of Nov 20, 2026